妊娠期子宫肌瘤的自然转归及其影响因素分析

doi:10.3969/j.issn.1006-7795.2021.01.016

首都医科大学学报 ›› 2021, Vol. 42 ›› Issue (1): 94-100.doi: 10.3969/j.issn.1006-7795.2021.01.016

妊娠期子宫肌瘤的自然转归及其影响因素分析

赵静¹, 罗美², 王淑珍^1*, 丁灵¹, 郑婧¹

1.首都医科大学附属北京朝阳医院妇产科,北京 100020;
2.首都医科大学附属北京潞河医院妇产科,北京 101100

收稿日期:2020-10-16 出版日期:2021-02-21 发布日期:2021-02-02
基金资助:
国家自然科学基金青年基金(82003245), 北京市医管局扬帆计划重点项目(ZYLX201713)。

Natural modification of uterine fibroids during pregnancy

Zhao Jing¹, Luo Mei², Wang Shuzhen^1*, Ding Ling¹, Zheng Jing¹

1. Department of Obstetrics and Gynecology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China;
2. Department of Obstetrics and Gynecology, Beijing Luhe Hospital, Capital Medical University, Beijing 101100, China

Received:2020-10-16 Online:2021-02-21 Published:2021-02-02
Contact: ^*E-mail:darrywang2003@163.com
Supported by:
Youth Fund of National Natural Science Foundation of China(82003245),Key Projects of the Sailing Plan of Beijing Municipal Hospital Authority(ZYLX201713).

摘要/Abstract

摘要： 目的了解妊娠期子宫肌瘤自然转归的规律。方法采用纵向研究的方法,选取首都医科大学附属北京朝阳医院2011年1月1日至2017年12月31日期间建档、孕期监护的妊娠合并子宫肌瘤孕妇499例,对其子宫肌瘤在不同妊娠时期的最大径进行分析。结果 499个入组病例中,子宫肌瘤最大径中孕期较早孕期有显著增长[(3.94±2.02) cm vs (3.05±1.69) cm,t=13.94, P＜0.001)],晚孕早期较中孕期亦有显著增长[(4.18±2.22) cm vs (4.02±2.23) cm,t=2.96,P=0.003],而晚孕晚期较晚孕早期则无显著变化[(3.91±2.15) cm vs (3.93±2.17) cm,t=-0.81,P=0.417]。子宫肌瘤最大径自早孕期至晚孕晚期有显著增长[(2.94±1.70) cm vs (3.86±2.01) cm,t=-13.43,P＜0.001]。175例数据完整的患者中,不同初始最大径的子宫肌瘤孕期肌瘤变化的规律及幅度大致相同,其变化幅度与早孕期子宫肌瘤最大径、孕妇年龄、孕次、产次、肌瘤部位及数目均无关(P＞0.05)。子宫肌瘤整个孕期的最大径有38.3%出现在中孕期,33.1%在晚孕早期,21.1%在晚孕晚期,仅7.4%出现在早孕期。兼顾敏感度和特异度的情况下,当早孕期子宫肌瘤最大径超过4 cm时,对孕期子宫肌瘤将会显著增大(＞3 cm)的预测效果最好,敏感度为83.33%,特异度为76.07%。结论妊娠期子宫肌瘤在早孕至中孕期有显著增长且增幅最大,至晚孕早期增幅明显放缓,至晚孕晚期大部分肌瘤较前缩小,不同初始最大径的子宫肌瘤表现出大致相似的变化规律。

关键词: 妊娠期, 子宫肌瘤, 最大径, 自然转归

Abstract: Objective To explore the natural modification of uterine fibroids during pregnancy. Methods This longitudinal study enrolled a total of 499 cases of uterine fibroids during pregnancy in Beijing Chaoyang Hospital, Capital Medical University from January 1st 2011 to December 31st 2017. The fibroids' maximum diameter determined with ultrasound in different trimesters of pregnancy was extracted from medical record and analyzed respectively. Results A significant increase of uterine fibroids in diameter was observed from the first trimester to the second trimester of pregnancy [(3.94±2.02) cm vs (3.05±1.69)cm,t=13.94, P＜0.001)],and from the second trimester to early third trimester [(4.18±2.22) cm vs (4.02±2.23) cm,t=2.96,P=0.003)], while no significant change in size of fibroids was seen between the early and the late third trimester [(3.93±2.17) cm vs (3.91±2.15) cm,t=-0.81,P=0.417]. A progressive increase in the diameter of fibroids was detected from the first trimester to the late third trimesters [(2.94±1.70) cm vs (3.86±2.01) cm, t=-13.43,P<0.001]. However this kind of growth trend had proved to have no relation to the initial maximum diameter detected in the first trimester, patient age, obstetric history (gravidity, parity),location or number of fibroids (P＞0.05). In 175 cases with complete data (ultrasound results in 4 periods of pregnancy respectively), 38.3% of the maximum diameter of fibroids throughout pregnancy occurred in the second trimester, while 33.1% in the early third trimester, 21.1% in the late third trimester, and only 7.4% occurred in the first trimester. Taking both sensitivity and specificity into consideration, the maximum diameter of fibroid in the first trimester larger than 4 cm showed the most predictive value that the fibroids would be significantly enlarged during pregnancy (>3 cm), with a sensitivity of 83.33% and specificity of 76.07%. Conclusions There was a significant increase, also the largest increment in uterine fibroids during pregnancy from the first to the second trimester. The increase slowed down progressively in the early third trimester, followed by a subsequent decrease in the late third trimester. The growing trend of uterine fibroids with different initial sizes were similar to one another.

Key words: pregnancy, uterine fibroids, maximum diameter, natural modification

中图分类号:

R713

赵静, 罗美, 王淑珍, 丁灵, 郑婧. 妊娠期子宫肌瘤的自然转归及其影响因素分析[J]. 首都医科大学学报, 2021, 42(1): 94-100.

Zhao Jing, Luo Mei, Wang Shuzhen, Ding Ling, Zheng Jing. Natural modification of uterine fibroids during pregnancy[J]. Journal of Capital Medical University, 2021, 42(1): 94-100.

参考文献

[1] Drayer S M, Catherino W H. Prevalence, morbidity, and current medical management of uterine leiomyomas[J]. Int J Gynecol Obstetr,2015, 131(2):117-122.
[2] Donnez J, Dolmans M M. Uterine fibroid management: from the present to the future[J]. Hum Reprod Update,2016, 22(6):665-686.
[3] Borgato S,Vitagliano A,Vitale Salvatore G,et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature[J].Arch Gynecol Obstetr,2018,297(4):823-835.
[4] Se J L, Hyun S K, Sunghun N, et al. Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study[J]. BMC Pregnancy Childbirth, 2020, 20(1):716.
[5] Rault E, Delorme P, Goffinet F, et al. Impact of history of myomectomy on preterm birth risk in women with a leiomyomatous uterus: a propensity score analysis[J]. BMC Pregnancy Childbirth, 2020, 20(1):720.
[6] Pérez-Roncero G R, López-Baena M T, Ornat L, et al. Uterine fibroids and preterm birth risk: A systematic review and meta-analysis[J]. J Obstetr Gynaecol Res, 2020, 46(9):1711-1727.
[7] Kasuga Y, Lin B L, Kim S H, et al. The association between placenta implantation at prior myomectomy locations and perinatal outcomes in pregnant women who previously underwent one-step hysteroscopic myomectomy[J]. Gynecol Minim Invasive Ther, 2020, 9(2): 54-58.
[8] Shavell V I, Thakur M, Sawant A, et al. Adverse obstetric outcomes associated with sonographically identified large uterine fibroids[J]. Fertil Steril, 2012, 97(1):107-100.
[9] Stewart E A, Nicholson W K, Bradley L, et al. The burden of uterine fibroids for african-american women: results of a national survey[J]. J Women's Health,2013, 22(10):807-816.
[10]Lam S J, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome[J]. Am J Obstet Gynecol,2014, 211(4):395.
[11]Ciavattini A, Delli Carpini G, Clemente N, et al. Growth trend of small uterine fibroids and human chorionic gonadotropin serum levels in early pregnancy: an observational study[J]. Fertil Steril,2016, 105(5):1255-1260.
[12]Ciavattini A, Carpini G D, Nicolò C, et al. Growth trend of small uterine fibroids and human chorionic gonadotropin serum levels in early pregnancy: an observational study[J]. Fertil Steril, 2016, 105(5):1255-1260.
[13]Vitagliano A, Noventa M, Attilio D S S, et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature[J]. Arch Gynecolo Obstet, 2018, 297(14):823-835.
[14]Vivo A D, Mancuso A, Giacobbe A, et al. Uterine myomas during pregnancy: a longitudinal sonographic study[J]. Ultrasound Obstet Gynecol,2011, 37(3):361-365.
[15]Neiger R, Sonek J D, Croom C S, et al. Pregnancy-related changes in the size of uterine leiomyomas[J]. J Reprod Med, 2006, 51(9):671-674.
[16]Chill H H, Karavani G, Rachmani T, et al. Growth pattern of uterine leiomyoma along pregnancy[J]. BMC Women's Health, 2019, 19(1):100.
[17]Lev-Toaff A S, Coleman B G, Arger P H, et al. Leiomyomas in pregnancy: sonographic study[J]. Radiology,1987,164(2):375-380.
[18]子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志, 2017, 52(12):793-800.

妊娠期子宫肌瘤的自然转归及其影响因素分析

Natural modification of uterine fibroids during pregnancy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	路畅, 胡江涛, 李金皎, 姜海利. 剖宫产分娩中不同类型子宫肌瘤剔除术的临床特征分析[J]. 首都医科大学学报, 2022, 43(4): 653-657.
[2]	元沙沙, 马燕, 吴南楠, 许月超, 杨龙艳, 柯静, 赵冬. 妊娠期血糖异常者葡萄糖激酶基因突变筛查[J]. 首都医科大学学报, 2020, 41(1): 45-49.
[3]	王蕤, 徐品颖, 肖利. 妊娠期显性糖尿病与妊娠期糖尿病在妊娠晚期临床特点的比较[J]. 首都医科大学学报, 2017, 38(1): 103-107.
[4]	蒋子雯, 周志敏, 唐红波, 杜博, 张其清, 代荫梅. 乙酰普鲁兰纳米粒子BeWo b30细胞毒性及摄取研究[J]. 首都医科大学学报, 2016, 37(4): 418-423.
[5]	李晶华, 黄文燕, 张瑞, 马雪莲, 史从宁, 李文君, 冯力民. Ⅱ型子宫黏膜下肌瘤术前超声评估MFM的临床意义[J]. 首都医科大学学报, 2016, 37(4): 523-528.
[6]	李力, 张谦. 妊娠糖尿病妇女和正常妊娠妇女人体成分的比较[J]. 首都医科大学学报, 2015, 36(6): 982-985.
[7]	王红梅, 代荫梅, 田玉翠, 薛智方. 子宫肌瘤对双胎胎儿生长发育及新生儿结局的影响[J]. 首都医科大学学报, 2015, 36(4): 573-577.
[8]	赵园园, 宋洋, 马海莲, 冀明, 李鹏, 张澍田. 妊娠期胃食管反流病的症状特点及其对生活质量影响的研究[J]. 首都医科大学学报, 2014, 35(5): 617-620.
[9]	卢永军, 阮祥燕, 田玄玄, 刘玉兰, 甄洁, Diethelm Wallwiener, Alfred O. Mueck. 多囊卵巢综合征综合治疗对妊娠结局的影响[J]. 首都医科大学学报, 2014, 35(4): 428-432.
[10]	周莉;吴连方;范玲;李晓玉. 妊娠期糖尿病孕妇产后糖代谢异常的影响因素[J]. 首都医科大学学报, 2012, 33(2): 263-267.
[11]	宋伟;王欣. 妊娠期急性脂肪肝9例分析[J]. 首都医科大学学报, 2011, 32(4): 569-571.
[12]	李国政;苑敏;吴子芳;刘增强;刘丽艳. 子宫肌瘤与子宫腺肌病超声造影鉴别诊断的价值[J]. 首都医科大学学报, 2011, 32(2): 293-296.
[13]	王佳茵;张海珍;关云谦;谢峰. 汉族人群雌激素受体β基因多态性与子宫肌瘤的关系[J]. 首都医科大学学报, 2010, 31(5): 660-663.
[14]	钱睿亚. 经阴道子宫肌瘤剔除25例临床分析[J]. 首都医科大学学报, 2010, 31(2): 272-275.
[15]	贺昕红;蔺莉. 妊娠期糖尿病孕妇血中肿瘤坏死因子α的变化[J]. 首都医科大学学报, 2007, 28(2): 243-245.